Global Biopharmaceutical Fermentation Systems Market to Reach $17.3 Billion by 2030
The global market for Biopharmaceutical Fermentation Systems estimated at US$12.7 Billion in the year 2023, is expected to reach US$17.3 Billion by 2030, growing at a CAGR of 4.5% over the period 2023-2030. Upstream Products, one of the segments analyzed in the report, is expected to record 3.7% CAGR and reach US$5.9 Billion by the end of the analysis period. Growth in the Downstream Products segment is estimated at 4.9% CAGR for the next 7-year period.
The U.S. Market is Estimated at $3.8 Billion, While China is Forecast to Grow at 4.3% CAGR
The Biopharmaceutical Fermentation Systems market in the U.S. is estimated at US$3.8 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.1 Billion by the year 2030 trailing a CAGR of 4.3% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.6% and 3.6% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook